New parameters for assessing glucose metabolism in elderly patients with diabetes mellitus
Authors:
Kvapil Milan; Nováková Martina; Matvejeva Darina; Tománková Lucie; Piťhová Pavlína
Authors‘ workplace:
Geriatrická interní klinika 2. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice v Motole, Praha
Published in:
Geriatrie a Gerontologie 2024, 13, č. 2: 77-80
Category:
Review Article
Overview
New options offering technological advances in continuous blood glucose measurement will certainly be used by diabetics over 65 years of age. Several new indexes have been established to evaluate the results of glucose measurement by the sensor. Their importance and contribution to the treatment of diabetics and the elderly is summarized in a clear text.
Keywords:
glucose sensor, glucose management indicator (GMI), time in range (TIR)
Sources
1. Teo E, Hassan N, Tam W, Koh S. Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis. Diabetologia 2022; 65(4): 604–619.
2. Seidu S, Kunutsor SK, Ajjan RA, et al. Efficacy and safety of continuous glucose monitoring and intermittently scanned continuous glucose monitoring in patients with type 2 diabetes: a systematic review and meta-analysis of interventional evidence. Diabetes Care 2024; 47(1): 169–179.
3. Bergenstal RM, Beck RW, Close Kl, et al. Glucose Management Indicator (GMI): a new term for estimating A1C from continuous glucose monitoring. Diabetes Care 2018; 41(11): 2275–2280.
4. Beck RW, Connor CG, Mullen DM, et al. The fallacy of average: How using HbA1c alone to assess glycemic control can be misleading. Diabetes Care 2017; 40(8): 994–999.
5. Toschi E, Slyne C, Sifre K, O’Donnell R, et al. The relationship between CGM-derived metrics, A1C, and risk of hypoglycemia in older adults with type 1 diabetes. Diabetes Care 2020; 43(10): 2349–2354.
6. Fang M, Wang D, Rooney MR, et al. Performance of the Glucose Management Indicator (GMI) in type 2 diabetes. Clin Chem 2023; 69(4): 422–428.
7. Selvin E, Wang D, Rooney MR, et al. The associations of mean glucose and time in range from continuous glucose monitoring with HbA1c in adults with type 2 diabetes. Diabetes Technol Ther 2023; 25(1): 86–90.
8. Ling J, Ng JKCC, Lau ESH, et al. Continuous glucose monitoring metrics in the assessment of glycemia in moderate-to-advanced CKD in diabetes. Kidney Int Rep 2022; 7(6): 1354–1363.
9. Oriot P, Viry C, Vandelaer A, et al. Discordance between glycated hemoglobin A1c and the glucose management indicator in people with diabetes and chronic kidney disease. J Diabetes Sci Technol 2023; 17(6): 1553–1562.
10. Perlman JE, Gooley TA, McNulty B, et al. HbA1c and glucose management indicator discordance: a real-world analysis. Diabetes Technol Ther 2021; 23(4): 253–
258.
11. Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care 2019; 42(8): 1593–1603.
12. Nováková M, Kotvová V, Tománková L, et al. Okamžité monitorování glukózy u seniorů hospitalizovaných na Geriatrické interní klinice 2. LF UK a FN Motol. Kazuistiky v diabetologii 2024; 22(2). V tisku.
Labels
Geriatrics General practitioner for adults Orthopaedic prostheticsArticle was published in
Geriatrics and Gerontology
2024 Issue 2
Most read in this issue
- Frailty – relationship to selected comorbidities in hospitalized seniors over 28 years
- Diabetic foot syndrome – a serious complication of diabetes mellitus even in the elderly
- Benefits and risks of new antidiabetic drugs for the treatment of elderly diabetics
- Consiliary palliative team and its benefits for polymorbid geriatric patients